Monday, January 16, 2017

Weekly Links January 16th , 2017



“MUST READ”
    • Hundreds of acres of gene-edited crops have already been grown in several states, unencumbered by oversight or regulations. And a few people have eaten them already. “This is not Frankenfood,” said André Choulika, chief executive of Cellectis, one of the companies developing gene-edited crops.
In October, Cellectis hosted a dinner at Benoit New York, the Alain Ducasse Manhattan restaurant, and served dishes made from its gene-edited soybeans and potatoes. Guests included professors, journalists and celebrities like Neil Patrick Harris, the actor.
TOOLS/TECHNIQUES
It’s been an interesting year for the field of genomics as next-gen sequencing technologies continue to emerge, evolve, and in some cases, fade to obscurity. This year also brought some big career and life events for yours truly. Let’s look at some …
HEALTH/MEDECINE
Despite its dangers, the gene appears to protect the brain from parasites. When the former nurse Jamie Tyrone learned that she carried two copies of a gene called ApoE4, she “lost hope and direction,” and her “days were filled with fear, anxiety and…
COMPANIES
Illumina, the largest maker of DNA sequencers, is launching a new DNA sequencer with new architecture it says could push the cost of decoding a human genome from $1,000 to $100–although that decrease will not come for years. via Pocket
At today's J.P. Morgan Healthcare Conference Illumina made a number of small announcements -- some new partnerships, Firefly on track for launch later this year, launch of the single cell workflow partnered with Bio-Rad. via Pocket
Illumina announced new sequencers, NovaSeq 5000 and 6000, that could potentially reduces the cost of human genome sequencing to $100 in the future. via Pocket
Hokay, that's plenty of law for me. I don't have any plans to hang out a Robison & Shih Tzu, Specialists in Patent Law sign; I'm done with formal schooling. Again, all we have seen is UC's side of the story. via Pocket
San Diego’s Edico Genome is now in its fourth year as a startup, and well into the hard slog of striking partnership deals, generating revenue, and building a business. via Pocket
The imaging technologies used in the medical and biotech fields may be powerful and indispensable for research and diagnosis, but they can also be slow and clumsy — relics of techniques that go back decades. via Pocket
SOMETHING DIFFERENT
Need for fillings could be reduced in future as study reveals natural ability of teeth to repair themselves can be enhanced using Alzheimer’s drug Dentists have devised a treatment to regenerate rotten teeth that could substantially reduce the need …

No comments:

Post a Comment